20 May 2015
As part of our Healthy Outlook: Conquering Cancer in the 21st Century blog series, we wanted to highlight a new report from IMS Institute for Healthcare Informatics that examines the global market for oncology treatment. According to the report, cancer care is evolving and improving as new therapies emerge and innovation continues, underscoring the importantance of a competitive biopharmaceutical marketplace to control costs and push biopharmaceutical manufacturers to innovate. Here are some key highlights from the report:
With innovation progressing rapidly, we have more hope than ever before for clinical outcomes when patients have access to treatments. We will continue to provide new information on the state of cancer care and expectations for the future, so be sure to check back in with the Healthy Outlook series.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Health Ministry registered Russian drug for ankylosing spondylitis
06 May 2024
How gut enzymes could make universal donor blood possible
06 May 2024
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024